Jump to main content

博士論文

A Phase 1, Randomized, Placebo-Controlled Study of Molnupiravir in Healthy Japanese to Support Special Approval in Japan to Treat COVID-19

Icons representing 博士論文
The cover of this title could differ from library to library.

Available in National Diet Library

Find on the publisher's website

NDL Digital Collections

Digital data available（大分大学）

Check on the publisher's website

A Phase 1, Randomized, Placebo-Controlled Study of Molnupiravir in Healthy Japanese to Support Special Approval in Japan to Treat COVID-19

Persistent ID (NDL)
info:ndljp/pid/12652043
Material type
博士論文
Author
中村, 圭介
Publisher
大分大学
Publication date
2022
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
大分大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General)：

type:Thesis or Dissertation

Search by Bookstore

Search by Bookstore

Search by Bookstore

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
A Phase 1, Randomized, Placebo-Controlled Study of Molnupiravir in Healthy Japanese to Support Special Approval in Japan to Treat COVID-19
Author/Editor
中村, 圭介
Author Heading
中村, 圭介
Publication, Distribution, etc.
大分大学
Publication Date
2022
Publication Date (W3CDTF)
2022
Alternative Title
COVID-19 治療薬モルヌピラビルの日本における特例承認取得をサポートする日本人健常人における第 1 相プラセボ比較ランダム化試験
Degree grantor/type
大分大学
Date Granted
2022-12-21